Purification of erythropoietin from human plasma samples using an immunoaffinity well plate

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 878, Issue 23, 2010, Pages 2117-2122

  Mallorqui J ^a,b   Llop, E ^a   de Bolos C ^a   Gutierrez Gallego R ^a,b   Segura, J ^a,b   Pascual, J A ^a,b  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Doping; Erythropoietin; Human; Immunoaffinity; N Glycolyl neuraminic acid; Plasma

Indexed keywords

CROSS CONTAMINATION; DOPING; DOPING CONTROL; ERYTHROPOIETIN; GLYCOSYLATED; HPLC-FLD; HUMAN ERYTHROPOIETIN; HUMAN PLASMA SAMPLES; IMMUNOAFFINITY; ISOFORMS; MICRO WELLS; OPERATING CONDITION; POLYVINYL PYRROLIDONE; SDS-PAGE; SIALIC ACIDS; WELL PLATES;

ACIDS; CARBOXYLIC ACIDS; PLASMA (HUMAN);

PLASMAS;

ERYTHROPOIETIN; GLYCOPROTEIN; N GLYCOLOYLNEURAMINIC ACID; POVIDONE; RECOMBINANT ERYTHROPOIETIN;

ALKALINITY; ANALYTIC METHOD; ANTIBODY AFFINITY; ARTICLE; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PLASMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PURIFICATION; BLOOD; DEVICES; ENZYME LINKED IMMUNOSORBENT ASSAY; ISOELECTRIC FOCUSING; ISOLATION AND PURIFICATION; PROCEDURES; STANDARD;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; HUMANS; ISOELECTRIC FOCUSING; REFERENCE STANDARDS;

EID: 77955049374     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.06.025     Document Type: Article

References (20)

1. Lai P.H., Everett R., Wang F.F., Arakawa T., Golwasser E. J. Biol. Chem. 1986, 261(7):3116.
2. Jelkmann W. Intern. Med. 2004, 43(8):649.
3. Macdougall I.C., Eckardt K.U. Lancet 2006, 368:947.
4. World Anti-Doping Agency (WADA) 2009. Available at (accessed 10 March 2009). http://www.wada-ama.org/rtecontent/document/2009_Prohibited_List_ENG_Final_20_Sept_08.pdf.
5. Lasne F., Martin L., Crepin N., de Ceaurriz J. Anal. Biochem. 2002, 311:119.
6. Kohler M., Ayotte C., Desharnais P., Flenker U., Lüdke S., Thevis M., Völker-Schanzer E., Schänzer W. Int. J. Sports Med. 2008, 29(1):1.
7. Reichel C., Kulovics R., Jordan V., Watzinger M., Geisendorfer T. Drug Test. Anal. 2009, 1:43.
8. Llop E., Gutiérrez-Gallego R., Segura J., Mallorquí J., Pascual J.A. Anal. Biochem. 2008, 383(2):243.
9. Hokke C.H., Bergwerff A.A., van Dedem G.W., van Oostrum J., Kamerling J.P., Vliegenthart J.F. FEBS Lett. 1990, 275(1-2):9.
10. Nimtz M., Martin W., Wray V., Klöppel K.D., Augustin J., Conradt H.S. Eur. J. Biochem. 1993, 213(1):39.
11. Skibeli V., Nissen-Lie G.A., Noreau A., Torjesen P., Hemmersbach P., Birkeland K.I. Recent Advances in Doping Analysis 1998, 313. Sport verlag Strauss, Köln. W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (Eds.).
12. Skibeli V., Nissen-Lie G., Torjesen P. Blood 2001, 98(13):3626.
13. Lasne F., Martin L., Martin J.A., de Ceaurriz J. Int. J. Biol. Macromol. 2007, 41(3):354.
14. Llop E., Gutiérrez-Gallego R., Belalcázar V., Gerwig G.J., Kamerling J.P., Segura J., Pascual J.A. Proteomics 2007, 7(23):4278.
15. Butler J.E. Methods 2000, 22(1):4.
16. Giménez E., De Bolós C., Belalcazar V., Andreu D., Borrás E., De la Torre B.G., Barbosa J., Segura J., Pascual J.A. Anal. Bioanal. Chem. 2007, 388(7):1531.
17. World Anti-Doping Agency (WADA) 2009. Available at (accessed 12 March 2010). http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-IS-Laboratories/WADA_TD2009EPO_EN.pdf.
18. Belalcázar V., Segura J., de Bolòs C., Peng S.H., Gutiérrez-Gallego R., Llop E., Pascual J.A., Poster 15th IFCC-FESCC European Congress of Clinical Chemistry and Laboratory Medicine 2003, Euromedlab2003, Barcelona.
19. Mallorquí J., Gutiérrez-Gallego R., Segura J., de Bolòs C., Pascual J.A. J. Pharm. Biomed. Anal. 2010, 51(1):255.
20. Mallorquí J., Segura J., de Bolòs C., Gutiérrez-Gallego R., Pascual J.A. Haematologica 2008, 93(2):313.